Navigate Fool.com
Will CBPO beat
the market?
Community Rating: 1 Star: Ominous

39.23 -0.93 (-2.30%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.50
Previous Close $40.16
Daily Range $37.11 - $40.50
52-Week Range $19.10 - $40.96
Market Cap $916.7M
P/E Ratio 20.49
Dividend (Yield) $0.00 (0.0%)
Volume 26,301
Average Daily Volume 18,900
Current FY EPS $0.00

How do you think CBPO
will perform against the market?

Top CBPO Bull/Bear Pitches


giftofgod (< 20)
Submitted July 1, 2010

I looked at the top bull pitch and thought, wow that is a better bear pitch except for appearing on the MFI list. This company seems to be one of the few undervalued companies on my list. The growth i … More

0 Replies Reply Report this Post

bradford86 (< 20)
Submitted June 1, 2011

fraud :-)

0 Replies Reply Report this Post

News & Commentary

3 Humongous Health-Care Stocks This Week

Find out which healthcare stocks deserved gold medals this week.

3 Stocks Near 52-Week Highs Worth Selling

Are these three stocks sells or belles? You be the judge!

Is This the Most Undervalued Biotech of 2013?

Biotechs roared in 2013. Questcor was no exception, but it still just might be the most undervalued biotech of the year.

Investors' 3 Most Loved Biotech Stocks

The biotech sector is the roulette wheel of Wall Street, but these three biotech stocks have the lowest short interest in the entire sector.

NASDAQ Changes Up Biotech Index Members & Weightings

China's Economic Miracle Going Down the Tubes: 10 Stocks to Watch

Chinese Biotech: Novartis Starts Moving Jobs to China, Away From Europe and U.S.

11 Health-Care Stocks Insiders Are Buying

What the insiders are doing can tell us a lot.

3 Stocks With Big Potential

This month's Modified Foolish 8 companies.

This Month's Foolish 8 Stocks

Small-cap companies with outstanding potential.

See More CBPO News...





China Biologic Products (CBPO) Description

China Biologic Products Incorporated is a biopharmaceutical company and through its indirect majority-owned Chinese subsidiaries it is mainly engaged in the research development and manufacturing of plasma-based pharmaceutical products in China. Website: http://www.ctbb.com.cn/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks